Reply to “Comment on Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005”

Vaccines (Mar 2019)

Affiliations

Janine Paynter: Department of General Practice and Primary Health, University of Auckland, Auckland, 1142, New Zealand
Felicity Goodyear-Smith: Department of General Practice and Primary Health, University of Auckland, Auckland, 1142, New Zealand
Jane Morgan: Sexual Health Services Waikato District Health Board and Honorary Senior Lecturer, School of Medicine, University of Auckland, Auckland, 1142, New Zealand
Peter Saxton: Department of Social and Community Health, University of Auckland, Auckland, 1142, New Zealand
Steven Black: Department of Pediatrics, Cincinnati Children’s Hospital, Cincinnati, OH 45229-3039, USA
Helen Petousis-Harris: Immunisation Advisory Centre, Department of General Practice and Primary Health Care, University of Auckland, Auckland, 1142, New Zealand

Abstract

Kenyon (2019) is correct to suggest that there is limited evidence of longer term effectiveness.[...]